Semaphorins in cancer: Biological mechanisms and therapeutic approaches

Michael Rehman, Luca Tamagnone*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

71 Citazioni (Scopus)


The hallmarks of cancer include multiple alterations in the physiological processes occurring in normal tissues, such as cell proliferation, apoptosis, and restricted cell migration. These aberrant behaviors are due to genetic and epigenetic changes that affect signaling pathways controlling cancer cells, as well as the surrounding "normal" cells in the tumor microenvironment. Semaphorins and their receptors (mainly plexins and neuropilins) are aberrantly expressed in human tumors, and multiple family members are emerging as pivotal signals deregulated in cancer. Notably, different semaphorins can promote or inhibit tumor progression, depending on the implicated receptor complexes and responsive cell type. The important role of semaphorin signals in the regulation of tumor angiogenesis, invasion and metastasis has initiated multiple experimental approaches aimed at targeting these pathways to inhibit cancer. © 2012 Elsevier Ltd.
Lingua originaleEnglish
pagine (da-a)179-189
Numero di pagine11
Stato di pubblicazionePubblicato - 2013


  • Angiogenesis
  • Cell Biology
  • Developmental Biology
  • Invasion
  • Metastasis
  • Plexins
  • Semaphorins
  • Therapeutics
  • Tumor


Entra nei temi di ricerca di 'Semaphorins in cancer: Biological mechanisms and therapeutic approaches'. Insieme formano una fingerprint unica.

Cita questo